Caleb Rux, PharmD, BCIDP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Shionogi Inc.
    Topic:
    Cefiderocol use in immunocompromised patients
    Date added:
    05/12/2026
    Date updated:
    05/12/2026
    Relationship end date:
    07/31/2025
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Advisor
    Ineligible company:
    Pharmacosomos
    Topic:
    Trilaciclib utilization for chemotherapy induced neutropenia
    Date added:
    05/12/2026
    Date updated:
    05/12/2026
    Relationship end date:
    05/31/2026
Return to Illinois Summit on Antimicrobial Stewardship 2026